Peter Nigrovic

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    BMS
    Topic: 
    arthritis
    Date added: 
    11/16/2021
  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    BMS
    Topic: 
    arthritis
    Date added: 
    11/16/2021
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Miach Orthopaedics
    Topic: 
    DSMB chair
    Date added: 
    11/16/2021
    Relationship end date: 
    11/10/2021
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Cerecor
    Topic: 
    arthritis
    Date added: 
    11/16/2021
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Pfizer
    Topic: 
    arthritis
    Date added: 
    11/16/2021
  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Pfizer
    Topic: 
    neutrophil biology
    Date added: 
    11/16/2021
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Quench Bio
    Topic: 
    inflammasome
    Date added: 
    11/16/2021
    Relationship end date: 
    06/01/2020
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Sigilon
    Topic: 
    inflammation
    Date added: 
    11/16/2021
    Relationship end date: 
    05/01/2020
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Exo Therapeutics
    Topic: 
    inflammation
    Date added: 
    11/16/2021
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Novartis
    Topic: 
    arthritis
    Date added: 
    11/16/2021

Pages

Return to 152 Pediatric Grand Rounds: Update on Juvenile Idiopathic Arthritis” (121521)